US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Fidelity MSCI Health Care Index ETF

82.45

+1.311.61%

Post-market: 82.450.00000.00%19:30 EDT

Volume:159.48K

Turnover:13.12M

Market Cap:3.57B

PE:- -

High:82.56

Open:80.98

Low:80.93

Close:81.14

52wk High:85.46

52wk Low:67.77

Shares:43.35M

Float Shares:43.35M

Volume Ratio:0.63

T/O Rate:0.37%

Dividend:1.01

Dividend Rate:1.23%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Johnson & Johnson Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Benzinga Earnings

AbbVie reports ‘positive’ results from Phase 2 APEX Part B study of zumilokibart

AbbVie Starts Phase 2 Obesity Trial of Gubra-Discovered Amylin Analog ABBV-295

Abbvie: in Phase 1 Abbv-295 Study, All Dosing Regimens Resulted in Ls Mean Weight Loss up to About 10% over 3-Month Treatment Period

THOMSON REUTERS

Abbvie: 82.2% of All Abbv-295 Treated Participants Reported Mild Adverse Events as Highest Reported Ae Severity

THOMSON REUTERS

AbbVie Says Phase 1 ABBV-295 Study Shows Mean Weight Loss up to About 10% over 3-Month Period

AbbVie Says Mid-Stage Study of Atopic Dermatitis Treatment Meets Primary Goal

MT Newswires Live

2026 Nobel Prize Preview: Scientists Behind GLP-1 Weight-Loss Drugs Emerge as Leading Contenders

Lonza Strengthens Board with Nomination of Biotech Veteran Pearl Huang

Abbvie Highlights Positive Results from the Phase 2 Apex Part B Study of Zumilokibart in Moderate to Severe Atopic Dermatitis, as a Late Breaker at Eadv 2026

THOMSON REUTERS

AbbVie Presents Phase 2 APEX Part B Data for Zumilokibart in Moderate-to-Severe Atopic Dermatitis at EADV 2026

Actinogen Medical Adds Modest Number of New Shares to ASX Listing

Marvel Biosciences Raises $1.6 Million to Advance Lead Neurology Drug Into Phase 1 Trials

Eli Lilly reports results from TRIUMPH-2 Phase 3 trial

Lilly's Experimental Drug Cuts Weight by 21% in Diabetes Trial

Eli Lilly - Retatrutide 12 Mg Results in 49.6 Lb (20.8%) Weight Loss over 80 Weeks

THOMSON REUTERS

Lilly's Triple Agonist, Retatrutide, Delivered Substantial Weight Loss and A1c Reduction, Underscoring Its Potential Promise for People with Obesity and Type 2 Diabetes

THOMSON REUTERS

Eli Lilly - to Submit Biologics License Application for Retatrutide in Q1 2027

THOMSON REUTERS

Eli Lilly - 59.5% of Retatrutide 12 Mg Participants no Longer Meet Bmi Criteria for Obesity

THOMSON REUTERS

AbbVie Inc. Stock Outperforms Competitors Despite Losses on the Day

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/FHLC/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FHLC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FHLC\",,,,,undefined,":{"symbol":"FHLC","market":"US","secType":"STK","nameCN":"Fidelity MSCI Health Care Index ETF","latestPrice":82.45,"timestamp":1791576000000,"preClose":81.14,"halted":0,"volume":159477,"hourTrading":{"tag":"盘后","latestPrice":82.45,"preClose":82.45,"latestTime":"19:30 EDT","volume":40,"amount":3289.09,"timestamp":1791588606641,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.016144934680798646,"floatShares":43350000,"shares":43350000,"eps":0,"marketStatus":"Market Closed","change":1.31,"latestTime":"10-09 16:00:00 EDT","open":80.98,"high":82.56,"low":80.93,"amount":13118699.222520001,"amplitude":0.020089,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":81.14,"sharesOutstanding":39450000,"nav":81.116643,"aum":3601578949.2,"dividendRate":0.012302,"bidAskSpread":0.000403,"preHourTrading":{"tag":"盘前","latestPrice":81.42,"preClose":81.14,"latestTime":"08:48 EDT","volume":211,"amount":17176.34106,"timestamp":1791550123293,"change":0.28,"changeRate":0.003451,"amplitude":0.003451},"postHourTrading":{"tag":"盘后","latestPrice":82.45,"preClose":82.45,"latestTime":"19:30 EDT","volume":40,"amount":3289.09,"timestamp":1791588606641,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6302606688957819,"impliedVol":0.1618,"impliedVolPercentile":0.9004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FHLC\",,,,,undefined,":{"symbol":"FHLC","floatShares":43350000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6302606688957819,"shares":43350000,"dividePrice":1.0143,"high":82.56,"amplitude":0.020089,"preClose":81.14,"low":80.93,"week52Low":67.772,"pbRate":"--","week52High":85.4649,"institutionHeld":0,"latestPrice":82.45,"eps":0,"divideRate":0.012302,"volume":159477,"delay":0,"ttmEps":0,"open":80.98,"prevYearClose":74.28,"prevWeekClose":80.6,"prevMonthClose":81.7,"prevQuarterClose":81.7,"fiveDayClose":80.6,"twentyDayClose":80.3,"sixtyDayClose":78.61},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FHLC\",params:#limit:5,,,undefined,":[{"date":"2026-09-18","symbol":"FHLC","amount":0.254,"announcedDate":"2026-09-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-18","defaultRemindTime":1789738200000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-22","payableDate":"2026-09-18","currency":"USD","dateTimestamp":1789704000000,"payDate":"2026-09-22"},{"date":"2026-06-18","symbol":"FHLC","amount":0.263,"announcedDate":"2026-06-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-18","defaultRemindTime":1781789400000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-18","currency":"USD","dateTimestamp":1781755200000,"payDate":"2026-06-23"},{"date":"2026-03-20","symbol":"FHLC","amount":0.229,"announcedDate":"2026-03-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-20","defaultRemindTime":1774013400000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-24","payableDate":"2026-03-20","currency":"USD","dateTimestamp":1773979200000,"payDate":"2026-03-24"},{"date":"2025-12-19","symbol":"FHLC","amount":0.272,"announcedDate":"2025-12-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-19","defaultRemindTime":1766154600000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-19","currency":"USD","dateTimestamp":1766120400000,"payDate":"2025-12-23"},{"date":"2025-09-19","symbol":"FHLC","amount":0.256,"announcedDate":"2025-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-19","defaultRemindTime":1758288600000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-19","currency":"USD","dateTimestamp":1758254400000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FHLC\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-22","value":0.117,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-23","value":0.125,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-22","value":0.137,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-20","value":0.132,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-21","value":0.134,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FHLC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FHLC\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671082132","title":"Johnson & Johnson Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2671082132","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671082132?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:05","pubTimestamp":1790762710,"startTime":"0","endTime":"0","summary":"Johnson &amp; Johnson reports Q3 earnings Oct. 13; EPS seen at $2.48, revenue $25.31B. Analysts are mostly bullish after positive Tremfya and Carvykti data.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/09/62072451/johnson-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts-5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","IE00B19Z3581.USD","LU0345769631.USD","LU1551013342.USD","JDOC","LU0072461881.USD","LU1221951129.SGD","LU0820561818.USD","LU1585245621.USD","BK4592","SG9999001176.SGD","IXJ","LU2468319806.SGD","LU1043141123.HKD","LU2213496289.HKD","LU1221951046.USD","LU1023059063.AUD","LU0234572021.USD","LU2505996509.AUD","BK4585","LU0122379950.USD","LU1983299246.USD","LU2456880835.USD","LU0787776722.HKD","XLV","MEDX","GDOC","IE000F7OJYX1.SGD","PJP","LU0234570918.USD","SG9999013999.USD","IYH","TRUH","LU2471134523.USD","FHLC","IHE","LU1506573853.SGD","IE0002141913.USD","FTXH","LU0545039389.USD","IE00BJT1NW94.SGD","LU0320765646.SGD","JNJ","LU1929549753.HKD","IE00BVYPNW00.USD","RXL","VHT","LU1196500208.SGD","LU0511384066.AUD","LU1059921491.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671089252","title":"AbbVie reports ‘positive’ results from Phase 2 APEX Part B study of zumilokibart","url":"https://stock-news.laohu8.com/highlight/detail?id=2671089252","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671089252?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:55","pubTimestamp":1790762110,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) announced that the primary results from the ongoing Phase 2 APEX Part B Dose-Regimen-Finding Study, evaluating zumilokibart, in adult...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvie-reports-positive-results-from-phase-2-apex-part-b-study-of-zumilokibart-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvie-reports-positive-results-from-phase-2-apex-part-b-study-of-zumilokibart-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1934455277.USD","LU2347655073.USD","MEDX","LU1989772923.USD","ABBV","IE0002141913.USD","LU0203345920.USD","LU0820561909.HKD","BK4533","LU1670628061.USD","LU1720051108.HKD","FTXH","AGNG","LU1037948541.HKD","PPH","IXJ","JDOC","BK4566","LU2023251221.USD","GLAM","IE00B3PB1722.GBP","TRUH","IE00B2B36J28.USD","LU2089284900.SGD","BK4550","LU1057294990.SGD","VHT","LU0058720904.USD","IYH","LU0256863811.USD","IE0000B7K699.USD","LU0029864427.USD","LU0057025933.USD","IE00B19Z3581.USD","LU1430594728.SGD","IE000F7OJYX1.SGD","FHLC","IE00BJJMRZ35.SGD","IE00BLSP4452.SGD","PJP","IE000SO60NU8.SGD","RXL","LU2347655156.SGD","LU0472753341.HKD","LU0553294199.USD","XLV","LU0234572021.USD","LU1732800096.USD","LU0114720955.EUR","LU0395794307.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671208859","title":"AbbVie Starts Phase 2 Obesity Trial of Gubra-Discovered Amylin Analog ABBV-295","url":"https://stock-news.laohu8.com/highlight/detail?id=2671208859","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671208859?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:51","pubTimestamp":1790761876,"startTime":"0","endTime":"0","summary":"AbbVie starts Phase 2 obesity trial of Gubra-discovered amylin analog ABBV-295Gubra flagged AbbVie’s detailed Phase 1 results for obesity candidate ABBV-295, presented at EASD 2026 in Milan.Data showe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL9BGxfn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","LU0069063385.USD","LU0912757837.SGD","LU1718418525.SGD","LU1267930490.SGD","VHT","LU1037948897.HKD","TRUH","LU0456855351.SGD","JDOC","LU1430594728.SGD","LU2357305700.SGD","LU0170899867.USD","GLAM","LU0289739343.SGD","IE00BJT1NW94.SGD","LU1037948541.HKD","AGNG","PPH","IE00BVYPNV92.GBP","LU1934455863.HKD","FHLC","LU2237443622.USD","LU0859254822.USD","LU0820561909.HKD","LU0058720904.USD","LU0310799852.SGD","LU0289961442.SGD","LU0310800379.SGD","SG9999015952.SGD","LU2125909247.SGD","LU1983299246.USD","LU2112291526.USD","LU0985320562.USD","IYH","LU1923622614.USD","LU1989772923.USD","RXL","FTXH","XLV","IXJ","LU0417517546.SGD","PJP","IE00B4R5TH58.HKD","LU0738911758.USD","LU0661504455.SGD","LU2237443978.SGD","MEDX","LU0708994859.HKD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671270785","title":"Abbvie: in Phase 1 Abbv-295 Study, All Dosing Regimens Resulted in Ls Mean Weight Loss up to About 10% over 3-Month Treatment Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270785","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671270785?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:45","pubTimestamp":1790761500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nP8N3WW07N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0234570918.USD","LU0395794307.EUR","BK4559","VHT","XLV","LU1093756168.USD","PPH","BK4534","IE00BJT1NW94.SGD","LU0868494617.USD","AGNG","LU1934455194.USD","LU2129689431.USD","IE0004445239.USD","FHLC","TRUH","LU0320765646.SGD","MEDX","LU1839511570.USD","GLAM","LU1244550494.USD","SG9999015952.SGD","IE00BJJMRZ35.SGD","IE000BZT7R73.USD","IYH","LU0124676726.USD","JDOC","LU0058720904.USD","LU0198837287.USD","LU0289739343.SGD","RXL","LU0203345920.USD","IE00BBT3K403.USD","IE0002141913.USD","PJP","LU0057025933.USD","LU1236620750.USD","ABBV","LU0203347892.USD","LU0949170772.SGD","LU1934455863.HKD","IE00BGHQF631.EUR","LU1267930490.SGD","IXJ","FTXH","LU0820561909.HKD","LU1037948897.HKD","LU2087621335.USD","LU0417517546.SGD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671270207","title":"Abbvie: 82.2% of All Abbv-295 Treated Participants Reported Mild Adverse Events as Highest Reported Ae Severity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671270207?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:45","pubTimestamp":1790761500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nP8N3WW07N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1732800096.USD","BK4534","IYH","XLV","LU0158827948.USD","BK4139","LU2087621335.USD","LU2089283258.USD","IE00BLSP4239.USD","LU0128525929.USD","LU1244550577.SGD","IE000SO60NU8.SGD","ABBV","LU0943347566.SGD","LU0985320562.USD","RXL","TRUH","SG9999015978.USD","IE0002141913.USD","LU1989772840.SGD","FTXH","IXJ","LU1037948897.HKD","LU0795875169.SGD","LU1720051017.SGD","LU2237443549.SGD","IE00BSNM7G36.USD","PJP","IE0009355771.USD","LU0310800379.SGD","LU1267930573.SGD","MEDX","LU0395794307.EUR","IE000BZT7R73.USD","SG9999011175.SGD","GLAM","LU0545039389.USD","LU1989771016.USD","AGNG","LU2347655156.SGD","LU0289739699.SGD","LU1430594728.SGD","LU2357627491.SGD","JDOC","VHT","PPH","BK4533","LU0689626769.HKD","FHLC","LU0057025933.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671208209","title":"AbbVie Says Phase 1 ABBV-295 Study Shows Mean Weight Loss up to About 10% over 3-Month Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2671208209","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671208209?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:45","pubTimestamp":1790761500,"startTime":"0","endTime":"0","summary":"BRIEF-AbbVie Says Phase 1 ABBV-295 Study Shows Mean Weight Loss Up To About 10% Over 3-Month PeriodSept 30 -AbbVie Inc.ABBV.N:ABBVIE: IN PHASE 1 ABBV-295 STUDY, ALL DOSING REGIMENS RESULTED IN LS MEAN WEIGHT LOSS UP TO ABOUT 10% OVER 3-MONTH TREATMENT PERIODABBVIE: 82.2% OF ALL ABBV-295 TREATED PARTICIPANTS REPORTED MILD ADVERSE EVENTS AS HIGHEST REPORTED AE SEVERITYFurther company coverage:ABBV.N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nP8N3WW07N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","LU1496350502.SGD","LU1839511570.USD","LU0057025933.USD","LU1732800096.USD","LU0310799852.SGD","JDOC","LU0965508806.USD","SG9999015978.USD","IXJ","LU1291159041.SGD","LU1934455277.USD","LU0820561909.HKD","LU2089984988.USD","MEDX","RXL","LU2357305700.SGD","ABBV","BK4566","LU0114720955.EUR","TRUH","IYH","IE00BSNM7G36.USD","LU0310800379.SGD","AGNG","LU0689472784.USD","LU1548497426.USD","XLV","LU0432979614.USD","IE0004445239.USD","PPH","LU1670627923.USD","PJP","LU0256863902.USD","FTXH","IE00BN8TJ469.HKD","LU0472753341.HKD","LU0158827948.USD","LU1093756168.USD","FHLC","LU0320765646.SGD","VHT","LU1983299246.USD","LU1430594728.SGD","LU2112291526.USD","GLAM","LU0098860793.USD","LU0823416689.USD","SG9999015952.SGD","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671271707","title":"AbbVie Says Mid-Stage Study of Atopic Dermatitis Treatment Meets Primary Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2671271707","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671271707?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:14","pubTimestamp":1790756080,"startTime":"0","endTime":"0","summary":"AbbVie's  phase 2 dose-finding study of zumilokibart in adults with moderate-to-severe atopic dermatitis met its primary endpoint, with all three dose regimens achieving \"significantly\" higher response rates at week 16, compared with placebo, the company said Wednesday.The mid-dose regimen has been selected for phase 3 development.The findings support further evaluation of the drug's efficacy, safety and extended dosing intervals as a potential long-term treatment option, AbbVie said.Atopic dermatitis is a condition that causes dry, itchy and inflamed skin.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0009355771.USD","IE00B2B36J28.USD","FHLC","IE00BFTCPJ56.SGD","AGNG","LU0943347566.SGD","LU0289739343.SGD","IE000WAW04H5.SGD","LU1720051017.SGD","LU0456855351.SGD","GLAM","LU2023251221.USD","BK4550","LU0708994859.HKD","LU0965509010.AUD","LU1003077747.HKD","IXJ","IE00BVYPNW00.USD","ABBV","JDOC","LU0511384066.AUD","PPH","BK4534","LU0820561909.HKD","IE00BSNM7G36.USD","MEDX","BK4588","VHT","IE00BJJMRZ35.SGD","IYH","PJP","LU1670628061.USD","IE000SO60NU8.SGD","SG9999015945.SGD","LU1983299246.USD","XLV","RXL","LU0069063385.USD","LU1934455863.HKD","IE00BJT1NW94.SGD","LU2357305700.SGD","LU1585245621.USD","LU1496350171.SGD","LU0256863811.USD","LU0211328371.USD","LU1732800096.USD","IE00BDGV0183.EUR","TRUH","LU0965509101.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176833437","title":"2026 Nobel Prize Preview: Scientists Behind GLP-1 Weight-Loss Drugs Emerge as Leading Contenders","url":"https://stock-news.laohu8.com/highlight/detail?id=1176833437","media":"Deep News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176833437?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:00","pubTimestamp":1790755226,"startTime":"0","endTime":"0","summary":"The 2026 Nobel Prize laureates will be announced successively from October 5 to 12. In order to understand the list of hot candidates, The Scientist published scientists' predictions for the 2026...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIS","FXH","PJP","ELIL","CURE","RSPH","OZEM","LLYX","FHLC","NVOH","NBDS","PINK","THNR","MEDI","JDOC","NVOX","LLII","TRUH","IYH","NVOC","XLVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671278331","title":"Lonza Strengthens Board with Nomination of Biotech Veteran Pearl Huang","url":"https://stock-news.laohu8.com/highlight/detail?id=2671278331","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671278331?lang=en_us&edition=fundamental","pubTime":"2026-09-30 13:32","pubTimestamp":1790746351,"startTime":"0","endTime":"0","summary":"The latest update is out from Lonza Group Ltd ( ($CH:LONN) ). Lonza has nominated pharmaceutical and biotechnology veteran Pearl Huang as an indepe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lonza-strengthens-board-with-nomination-of-biotech-veteran-pearl-huang?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lonza-strengthens-board-with-nomination-of-biotech-veteran-pearl-huang?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","BK4581","SYNB","JDOC","BK4585","BK4588","DARP","IBB","XBI","FHLC","AGNG","XT","RSPH","FWD","IEIH","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671220206","title":"Abbvie Highlights Positive Results from the Phase 2 Apex Part B Study of Zumilokibart in Moderate to Severe Atopic Dermatitis, as a Late Breaker at Eadv 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220206","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671220206?lang=en_us&edition=fundamental","pubTime":"2026-09-30 13:30","pubTimestamp":1790746200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUAFW3VH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","IYH","FTXH","LU0820561818.USD","LU1551013425.SGD","LU1037948541.HKD","XLV","LU2125909247.SGD","LU1496350502.SGD","IE00BFTCPJ56.SGD","LU1929549753.HKD","LU0472753341.HKD","GLAM","LU2089284900.SGD","IE00BN8TJ469.HKD","LU1162221912.USD","FHLC","IE0002141913.USD","LU1093756325.SGD","LU1720051017.SGD","LU0256863902.USD","LU0170899867.USD","IXJ","PJP","MEDX","VHT","LU1548497426.USD","PPH","IE00B4R5TH58.HKD","TRUH","LU0949170772.SGD","LU0511384066.AUD","LU2125909593.SGD","LU0738911758.USD","LU0942090050.USD","LU2347655156.SGD","LU1061106388.HKD","BK4550","LU1718418525.SGD","LU1496350171.SGD","LU0708994859.HKD","LU1003077747.HKD","JDOC","IE00BSNM7G36.USD","RXL","AGNG","LU1670627923.USD","SG9999015986.USD","BK4581","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671220398","title":"AbbVie Presents Phase 2 APEX Part B Data for Zumilokibart in Moderate-to-Severe Atopic Dermatitis at EADV 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220398","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671220398?lang=en_us&edition=fundamental","pubTime":"2026-09-30 13:01","pubTimestamp":1790744482,"startTime":"0","endTime":"0","summary":"AbbVie presents Phase 2 APEX Part B data for zumilokibart in moderate-to-severe atopic dermatitis at EADV 2026AbbVie flagged new dermatology trial and real-world results slated for presentation at the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL524zqn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2347655073.USD","IYH","LU2133065610.SGD","LU1057294990.SGD","MEDX","LU0689472784.USD","LU2089284900.SGD","LU2089283258.USD","XLV","LU1291159041.SGD","LU1585245621.USD","LU1934455277.USD","TRUH","JDOC","LU0472753341.HKD","AGNG","LU2237443382.USD","LU1923622614.USD","LU1496350171.SGD","IE00B2B36J28.USD","LU2468319806.SGD","VHT","LU0738911758.USD","PJP","LU0661504455.SGD","IE000SO60NU8.SGD","LU1074936037.SGD","LU0417517546.SGD","LU0098860793.USD","LU0289739699.SGD","LU1934455863.HKD","LU1718418525.SGD","LU0320765646.SGD","SG9999015952.SGD","FTXH","FHLC","LU0949170772.SGD","LU0795875086.SGD","GLAM","PPH","IE000F7OJYX1.SGD","LU1244550494.USD","ABBV","IXJ","LU1061106388.HKD","IE00B19Z3581.USD","LU2357627491.SGD","RXL","LU2237443895.HKD","LU2129689431.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671222612","title":"Actinogen Medical Adds Modest Number of New Shares to ASX Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2671222612","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671222612?lang=en_us&edition=fundamental","pubTime":"2026-09-30 11:17","pubTimestamp":1790738242,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) has provided an announcement. Actinogen Medical Limited, an ASX-listed biotechnology company, has its ordinary full...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-adds-modest-number-of-new-shares-to-asx-listing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-adds-modest-number-of-new-shares-to-asx-listing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","RSPH","IEIH","JDOC","XT","BBP","AGNG","SYNB","IBB","BK4585","DARP","FWD","BK4588","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671122851","title":"Marvel Biosciences Raises $1.6 Million to Advance Lead Neurology Drug Into Phase 1 Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2671122851","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671122851?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:32","pubTimestamp":1790721144,"startTime":"0","endTime":"0","summary":"An update from Marvel Biosciences Corp ( ($TSE:MRVL) ) is now available. Marvel Biosciences Corp., a Calgary-based pre-clinical biotechnology compa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/marvel-biosciences-raises-1-6-million-to-advance-lead-neurology-drug-into-phase-1-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/marvel-biosciences-raises-1-6-million-to-advance-lead-neurology-drug-into-phase-1-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","IBB","LNGR","XT","DBB","FHLC","AGNG","IEIH","FWD","JDOC","RSPH","DARP","BBP","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671224004","title":"Eli Lilly reports results from TRIUMPH-2 Phase 3 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671224004","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671224004?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:10","pubTimestamp":1790719814,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY) and Company announced detailed results from TRIUMPH-2, a Phase 3 trial evaluating the efficacy and safety of retatrutide, an invest...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lilly-reports-results-from-triumph-2-phase-3-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lilly-reports-results-from-triumph-2-phase-3-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999014898.SGD","LU0323591593.USD","LU2491049909.HKD","LU2746668461.USD","LU2491050071.SGD","LU0823434583.USD","LU2237443382.USD","PPH","LU1629891620.HKD","JDOC","FHLC","LU1917777945.USD","LU0823434740.USD","LU0354030511.USD","LU2265009873.SGD","LU0256863811.USD","FTXH","IE00BJLML261.HKD","LU0079474960.USD","LU2089283258.USD","LU2324357040.USD","LU2750360997.AUD","SG9999017495.SGD","LU1291159041.SGD","IE00B1BXHZ80.USD","LU0786609619.USD","BK4581","LU1712237335.SGD","LU0061475181.USD","LU2361044865.SGD","LU2361045086.USD","LU0203202063.USD","SG9999014880.SGD","LU2361044949.HKD","LU2023251221.USD","SGXZ51526630.SGD","LU2237443549.SGD","LU0114720955.EUR","LU0353189763.USD","SG9999014906.USD","SGXZ99366536.SGD","IE0002141913.USD","LLY","LU0820561909.HKD","LU0964807845.USD","IE0009355771.USD","IE00B775H168.HKD","LU2552382215.SGD","LU1093756168.USD","LU0640476718.USD","IE00BJJMRX11.SGD","IE00BKDWB100.SGD","BK4588","LU0354030438.USD","SGXZ31699556.SGD","LU0122379950.USD","LU0096364046.USD","LU0210536198.USD","LU2106854487.HKD","BK4533","IE00BJJMRZ35.SGD","LU2168564065.EUR","BK4007","LU0820562030.AUD","LU0466842654.USD","LU2552382058.USD","IE00BK4W5M84.HKD","LU0198837287.USD","LU1057294990.SGD","LU2168564222.USD","IE00BFTCPJ56.SGD","LU0203201768.USD","LU0316494557.USD","LU0471298694.HKD","LU2168564495.EUR","LU2271345857.HKD","LU1127390331.HKD","AGNG","LU0385154629.USD","RXL","IE0005OL40V9.USD","LU0708995401.HKD","LU0094547139.USD","LU2756315664.SGD","LU2471134796.USD","SG9999015986.USD","LU0225283273.USD","LU0320765059.SGD","LU1814569148.SGD","LU1868837136.USD","THNR","LU2112291526.USD","OZEM","GB00BDT5M118.USD","LU1069344957.HKD","LU2471134523.USD","SG9999018857.SGD","LU2213496289.HKD","LU1868836591.USD","LU2237443978.SGD","LU2028103732.USD","LU0882574055.USD","LU2089984988.USD","LU2456880835.USD","LU2417539215.USD","IE00B2B36J28.USD","LU0234572021.USD","SGXZ57979304.SGD","LU0787776722.HKD","MHIP","LU1023059063.AUD","LLYX","IE00BWXC8680.SGD","LU0109394709.USD","LU0672654240.SGD","LU2087625088.SGD","LU0158827781.USD","LU2237438978.USD","LU0109391861.USD","LU1691799644.USD","SG9999014914.USD","LU1093756325.SGD","LU1720051108.HKD","SG9999001176.SGD","LU2896262040.SGD","IE00BFSS7M15.SGD","MEDX","LU2168564149.EUR","LU1323610961.USD","LU2237443895.HKD","WDNA","ELIS","LU2462591350.SGD","BK4599","SG9999018865.SGD","LU0256863902.USD","LU1551013425.SGD","LU2108987350.USD","LU2756315318.SGD","LU0238689110.USD","LU0345770308.USD","LU2211815571.USD","PJP","LU2462157665.USD","LU0320765992.SGD","LU0345770993.USD","LU1366192091.USD","LU2750360641.GBP","SGXZ81514606.USD","LU0820561818.USD","LLII","LU1061106388.HKD","LU1145028129.USD","LU2111349929.HKD","IE00BFSS8Q28.SGD","LU0417517546.SGD","LU2237443622.USD","LU2237443465.HKD","LU1720051017.SGD","LU1974910355.USD","IE00BKPKM429.USD","LU2491050154.USD","LU2552382132.HKD","SG9999015952.SGD","LU2746668974.SGD","LU0456855351.SGD","LU0106261372.USD","LU2063271972.USD","VHT","XLV","BK4534","LU2023250330.USD","LU1979441026.SGD","LU1548497426.USD","LU0289739699.SGD","LU0158827948.USD","HRTS","LU0943347566.SGD","LU1551013342.USD","LU0174119429.USD","LU0006306889.USD","IE00B4JS1V06.HKD","SG9999013999.USD","LU0689472784.USD","SG9999015945.SGD","SG9999001176.USD","CANC","IE0001KFT4U8.USD","IE00BJJMRY28.SGD","LU1983299246.USD","LU2468319806.SGD","LLYZ","LU0823416689.USD","LU1064131342.USD","LU1623119135.USD","IE00B7KXQ091.USD","TMED","BK4585","LU2357305700.SGD","LU1267930730.SGD","LU0471298777.SGD","LU2360106947.USD","LU1232071149.USD","LU1868836757.USD","LU1989771016.USD","LU2023250504.SGD","IHE","LU2264538146.SGD","ILDR","LU1280957306.USD","LU0882574139.USD","LU2471134952.CNY","LU2236285917.USD","GDOC","IE00B4R5TH58.HKD","IYH","LU0266013472.USD","LU0889565916.HKD","IE00B1XK9C88.USD","IE00BK4W5L77.USD","LU0432979614.USD","BK4516","LU1035775433.USD","IE00BN29S564.USD","LU1804176565.USD","LU0097036916.USD","MEDI","CURE","IE00BJT1NW94.SGD","LU0058720904.USD","LU2168563687.JPY","IE0004445015.USD","LU1988902786.USD","LU2602419157.SGD","LU1868836914.USD","LU0683600562.USD","LU2471134879.HKD","ELIL","TRUH","LU2089284900.SGD","LU2461242641.AUD","LU0133085943.USD","LU0353189680.USD","SG9999015978.USD","IE0004445239.USD","IXJ","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671402792","title":"Lilly's Experimental Drug Cuts Weight by 21% in Diabetes Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671402792","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671402792?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:06","pubTimestamp":1790719599,"startTime":"0","endTime":"0","summary":"Lilly's experimental drug cuts weight by 21% in diabetes trialSept 29 (Reuters)-Eli LillyLLY.Nsaid on Tuesday its experimental drug helped adults with type 2 diabetes and obesity lose an average of nearly 21% of their body weight in a late-stage clinical trial.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL4N45L216:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","LU2168564495.EUR","LU2324357040.USD","LU0417517546.SGD","LU0466842654.USD","IE00BN29S564.USD","IYH","LU2089283258.USD","LU2361044865.SGD","LU0203201768.USD","LU2112291526.USD","LU1988902786.USD","IE0001KFT4U8.USD","LU1979441026.SGD","IXJ","LU2264538146.SGD","GDOC","PJP","PPH","LU0106261372.USD","IE00B4JS1V06.HKD","LU0640476718.USD","LU0471298694.HKD","LU1712237335.SGD","LU1064131342.USD","LU2237443978.SGD","FTXH","LU0889565916.HKD","VHT","MEDI","SG9999015986.USD","SGXZ99366536.SGD","LU0823434740.USD","LU1629891620.HKD","LU1023059063.AUD","LU0122379950.USD","LU1917777945.USD","LU2237438978.USD","LU1069344957.HKD","LU2108987350.USD","LU1366192091.USD","LU2360106947.USD","LU2756315664.SGD","LU0353189763.USD","LU1127390331.HKD","LLYX","LU0353189680.USD","LU0114720955.EUR","LU1280957306.USD","LU2023251221.USD","GB00BDT5M118.USD","LU0094547139.USD","IE00B7KXQ091.USD","IE00BWXC8680.SGD","LU1804176565.USD","LU0820561818.USD","BK4581","LU1720051017.SGD","IE00BJJMRY28.SGD","LU2063271972.USD","LU0109391861.USD","FHLC","LU0174119429.USD","LU0385154629.USD","IE00BK4W5M84.HKD","BK4599","LU2237443622.USD","SG9999018865.SGD","LU0198837287.USD","LU2168563687.JPY","SGXZ31699556.SGD","LU0109394709.USD","LU1868837300.USD","LU2028103732.USD","LU2089284900.SGD","SG9999015952.SGD","LU1868836757.USD","BK4585","LU1989771016.USD","IE00B1XK9C88.USD","LU0210536198.USD","LU2089984988.USD","LU2552382215.SGD","IE00BKDWB100.SGD","LU0354030438.USD","IE00BKPKM429.USD","LU2552382058.USD","RXL","LU2491050154.USD","CURE","LU0320765992.SGD","LU2237443895.HKD","SGXZ81514606.USD","LU2750360997.AUD","IE00BJLML261.HKD","LU2462591350.SGD","LU0354030511.USD","IE00BFSS8Q28.SGD","IE0002141913.USD","LU2211815571.USD","BK4007","LU2168564065.EUR","BK4534","HRTS","LU2023250504.SGD","LU0964807845.USD","SG9999014906.USD","LU2462157665.USD","LU0158827781.USD","ELIS","LU0097036916.USD","LU1035775433.USD","SG9999014880.SGD","LU2111349929.HKD","LU1551013342.USD","LU1814569148.SGD","LU2552382132.HKD","LU2357305700.SGD","LU2236285917.USD","LU2750360641.GBP","SG9999015978.USD","LU2491050071.SGD","LU2756315318.SGD","MHIP","LU2271345857.HKD","LU2471134952.CNY","LU1057294990.SGD","LU2168564149.EUR","MEDX","LU0158827948.USD","THNR","IE0005OL40V9.USD","LU2602419157.SGD","LU0787776722.HKD","IE00B4R5TH58.HKD","LU0820561909.HKD","LU0256863902.USD","LU0882574055.USD","LU0345770993.USD","LU1093756325.SGD","ILDR","CANC","IE00B775H168.HKD","LU1323610961.USD","LU2361045086.USD","LU1061106388.HKD","LU2361044949.HKD","LU1551013425.SGD","LU1720051108.HKD","LU2168564222.USD","LU0823434583.USD","IE00BJJMRX11.SGD","LU2471134796.USD","BK4533","IE0009355771.USD","LU0316494557.USD","LU0943347566.SGD","LU2237443465.HKD","SG9999014914.USD","LU0432979614.USD","LU1868836914.USD","LU2456880835.USD","SG9999018857.SGD","TMED","LU1983299246.USD","LU1232071149.USD","XLV","LU2237443382.USD","LU0320765059.SGD","BK4516","LU2746668974.SGD","LU2896262040.SGD","LU2491049909.HKD","IHE","LU2746668461.USD","SG9999013999.USD","LU0456855351.SGD","LU1093756168.USD","LU0256863811.USD","IE00B1BXHZ80.USD","LU2106854487.HKD","LU0238689110.USD","LU1868837136.USD","LU1868836591.USD","LU2265009873.SGD","OZEM","LU1548497426.USD","LU0266013472.USD","LLII","IE0004445239.USD","IE00BK4W5L77.USD","BK4588","LU0006306889.USD","LU0820562030.AUD","LU2023250330.USD","LU0345770308.USD","JDOC","LU0203202063.USD","LU2237443549.SGD","IE00BFSS7M15.SGD","IE00B2B36J28.USD","TRUH","WDNA","SG9999001176.SGD","LU0689472784.USD","SG9999017495.SGD","LU0683600562.USD","LU0823416689.USD","LU0133085943.USD","LU2471134523.USD","SG9999015945.SGD","LU0096364046.USD","LU0323591593.USD","LU0471298777.SGD","LU2461242641.AUD","IE00BJT1NW94.SGD","LU1291159041.SGD","SG9999014898.SGD","LU2417539215.USD","LU0708995401.HKD","LLYZ","LLY","LU0079474960.USD","LU2087625088.SGD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU0672654240.SGD","LU1267930730.SGD","SG9999001176.USD","LU2213496289.HKD","LU0061475181.USD","LU0786609619.USD","LU0289739699.SGD","ELIL","LU0882574139.USD","LU2471134879.HKD","LU1691799644.USD","LU1623119135.USD","LU0058720904.USD","LU0225283273.USD","IE0004445015.USD","AGNG","SGXZ51526630.SGD","IE00BJJMRZ35.SGD","LU1145028129.USD","SGXZ57979304.SGD","LU0234572021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671446240","title":"Eli Lilly - Retatrutide 12 Mg Results in 49.6 Lb (20.8%) Weight Loss over 80 Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2671446240","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671446240?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:00","pubTimestamp":1790719224,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1YN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999014898.SGD","LU0323591593.USD","LU2491049909.HKD","LU2746668461.USD","LU2491050071.SGD","LU0823434583.USD","LU2237443382.USD","PPH","LU1629891620.HKD","JDOC","FHLC","LU1917777945.USD","LU0823434740.USD","LU0354030511.USD","LU2265009873.SGD","LU0256863811.USD","FTXH","IE00BJLML261.HKD","LU0079474960.USD","LU2089283258.USD","LU2324357040.USD","LU2750360997.AUD","SG9999017495.SGD","LU1291159041.SGD","IE00B1BXHZ80.USD","LU0786609619.USD","BK4581","LU1712237335.SGD","LU0061475181.USD","LU2361044865.SGD","LU2361045086.USD","LU0203202063.USD","SG9999014880.SGD","LU2361044949.HKD","LU2023251221.USD","SGXZ51526630.SGD","LU2237443549.SGD","LU0114720955.EUR","LU0353189763.USD","SG9999014906.USD","SGXZ99366536.SGD","IE0002141913.USD","LLY","LU0820561909.HKD","LU0964807845.USD","IE0009355771.USD","IE00B775H168.HKD","LU2552382215.SGD","LU1093756168.USD","LU0640476718.USD","IE00BJJMRX11.SGD","IE00BKDWB100.SGD","BK4588","LU0354030438.USD","SGXZ31699556.SGD","LU0122379950.USD","LU0096364046.USD","LU0210536198.USD","LU2106854487.HKD","BK4533","IE00BJJMRZ35.SGD","LU2168564065.EUR","BK4007","LU0820562030.AUD","LU0466842654.USD","LU2552382058.USD","IE00BK4W5M84.HKD","LU0198837287.USD","LU1057294990.SGD","LU2168564222.USD","IE00BFTCPJ56.SGD","LU0203201768.USD","LU0316494557.USD","LU0471298694.HKD","LU2168564495.EUR","LU2271345857.HKD","LU1127390331.HKD","AGNG","LU0385154629.USD","RXL","IE0005OL40V9.USD","LU0708995401.HKD","LU0094547139.USD","LU2756315664.SGD","LU2471134796.USD","SG9999015986.USD","LU0225283273.USD","LU0320765059.SGD","LU1814569148.SGD","LU1868837136.USD","THNR","LU2112291526.USD","OZEM","GB00BDT5M118.USD","LU1069344957.HKD","LU2471134523.USD","SG9999018857.SGD","LU2213496289.HKD","LU1868836591.USD","LU2237443978.SGD","LU2028103732.USD","LU0882574055.USD","LU2089984988.USD","LU2456880835.USD","LU2417539215.USD","IE00B2B36J28.USD","LU0234572021.USD","SGXZ57979304.SGD","LU0787776722.HKD","MHIP","LU1023059063.AUD","LLYX","IE00BWXC8680.SGD","LU0109394709.USD","LU0672654240.SGD","LU2087625088.SGD","LU0158827781.USD","LU2237438978.USD","LU0109391861.USD","LU1691799644.USD","SG9999014914.USD","LU1093756325.SGD","LU1720051108.HKD","SG9999001176.SGD","LU2896262040.SGD","IE00BFSS7M15.SGD","MEDX","LU2168564149.EUR","LU1323610961.USD","LU2237443895.HKD","WDNA","ELIS","LU2462591350.SGD","BK4599","SG9999018865.SGD","LU0256863902.USD","LU1551013425.SGD","LU2108987350.USD","LU2756315318.SGD","LU0238689110.USD","LU0345770308.USD","LU2211815571.USD","PJP","LU2462157665.USD","LU0320765992.SGD","LU0345770993.USD","LU1366192091.USD","LU2750360641.GBP","SGXZ81514606.USD","LU0820561818.USD","LLII","LU1061106388.HKD","LU1145028129.USD","LU2111349929.HKD","IE00BFSS8Q28.SGD","LU0417517546.SGD","LU2237443622.USD","LU2237443465.HKD","LU1720051017.SGD","LU1974910355.USD","IE00BKPKM429.USD","LU2491050154.USD","LU2552382132.HKD","SG9999015952.SGD","LU2746668974.SGD","LU0456855351.SGD","LU0106261372.USD","LU2063271972.USD","VHT","XLV","BK4534","LU2023250330.USD","LU1979441026.SGD","LU1548497426.USD","LU0289739699.SGD","LU0158827948.USD","HRTS","LU0943347566.SGD","LU1551013342.USD","LU0174119429.USD","LU0006306889.USD","IE00B4JS1V06.HKD","SG9999013999.USD","LU0689472784.USD","SG9999015945.SGD","SG9999001176.USD","CANC","IE0001KFT4U8.USD","IE00BJJMRY28.SGD","LU1983299246.USD","LU2468319806.SGD","LLYZ","LU0823416689.USD","LU1064131342.USD","LU1623119135.USD","IE00B7KXQ091.USD","TMED","BK4585","LU2357305700.SGD","LU1267930730.SGD","LU0471298777.SGD","LU2360106947.USD","LU1232071149.USD","LU1868836757.USD","LU1989771016.USD","LU2023250504.SGD","IHE","LU2264538146.SGD","ILDR","LU1280957306.USD","LU0882574139.USD","LU2471134952.CNY","LU2236285917.USD","GDOC","IE00B4R5TH58.HKD","IYH","LU0266013472.USD","LU0889565916.HKD","IE00B1XK9C88.USD","IE00BK4W5L77.USD","LU0432979614.USD","BK4516","LU1035775433.USD","IE00BN29S564.USD","LU1804176565.USD","LU0097036916.USD","MEDI","CURE","IE00BJT1NW94.SGD","LU0058720904.USD","LU2168563687.JPY","IE0004445015.USD","LU1988902786.USD","LU2602419157.SGD","LU1868836914.USD","LU0683600562.USD","LU2471134879.HKD","ELIL","TRUH","LU2089284900.SGD","LU2461242641.AUD","LU0133085943.USD","LU0353189680.USD","SG9999015978.USD","IE0004445239.USD","IXJ","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671240445","title":"Lilly's Triple Agonist, Retatrutide, Delivered Substantial Weight Loss and A1c Reduction, Underscoring Its Potential Promise for People with Obesity and Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2671240445","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671240445?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:00","pubTimestamp":1790719224,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","LU0385154629.USD","LU0820561909.HKD","SGXZ99366536.SGD","LU0210536198.USD","LU0320765992.SGD","IXJ","IE00BK4W5L77.USD","LU0061475181.USD","LU0225283273.USD","LU2106854487.HKD","LU2471134796.USD","GDOC","LU1804176565.USD","BK4007","LU0097036916.USD","SG9999014898.SGD","TRUH","LU0882574055.USD","LU2237443622.USD","LU1868836914.USD","LLYZ","IE0004445239.USD","LU1093756325.SGD","IE00BFSS8Q28.SGD","LU1814569148.SGD","LU2213496289.HKD","LU2237443978.SGD","LU2471134879.HKD","LU2491050154.USD","VHT","LU0943347566.SGD","IYH","LU0640476718.USD","LU2552382058.USD","IE00B4JS1V06.HKD","LU0079474960.USD","LU1267930730.SGD","LU2264538146.SGD","LU1691799644.USD","FHLC","LU1127390331.HKD","LU0432979614.USD","LU0006306889.USD","SGXZ81514606.USD","LU1551013342.USD","LU0198837287.USD","XLV","SG9999018865.SGD","LU0316494557.USD","LU1064131342.USD","LU1623119135.USD","LU1868836591.USD","SG9999015986.USD","LU0256863902.USD","SG9999001176.SGD","LU2602419157.SGD","LU2237438978.USD","LU1551013425.SGD","IE00BKDWB100.SGD","LU1868837300.USD","MEDX","IE0002141913.USD","IHE","WDNA","LU2111349929.HKD","IE00BK4W5M84.HKD","LU0345770308.USD","IE00BJT1NW94.SGD","LU2357305700.SGD","BK4599","LU0106261372.USD","LU2063271972.USD","LU2168564495.EUR","LU0109391861.USD","FTXH","LU1720051108.HKD","LU0787776722.HKD","LU0820561818.USD","LU1323610961.USD","LU0109394709.USD","LU1979441026.SGD","LU2023251221.USD","LU2750360997.AUD","LU0174119429.USD","IE00B2B36J28.USD","LU0708995401.HKD","CURE","LU2750360641.GBP","LU1868836757.USD","LU1057294990.SGD","OZEM","LU1232071149.USD","LU2360106947.USD","BK4581","LU0882574139.USD","LU0672654240.SGD","LU1629891620.HKD","BK4534","BK4585","LU0683600562.USD","LU2168564065.EUR","IE00B7KXQ091.USD","GB00BDT5M118.USD","LU0266013472.USD","IE00BWXC8680.SGD","LU2361044865.SGD","LU0786609619.USD","LU2271345857.HKD","LU2552382215.SGD","IE0001KFT4U8.USD","LU2108987350.USD","SG9999013999.USD","SG9999017495.SGD","LU1988902786.USD","CANC","LU2087625088.SGD","LU2089283258.USD","IE00B4R5TH58.HKD","LU0823434583.USD","BK4516","LU2746668461.USD","LU2112291526.USD","LU1280957306.USD","LU0238689110.USD","LU0114720955.EUR","LU2361045086.USD","LLY","LU2491049909.HKD","LU2462591350.SGD","LU2211815571.USD","LU0823416689.USD","IE0005OL40V9.USD","LU0354030438.USD","LU1720051017.SGD","THNR","LU2756315318.SGD","LU2461242641.AUD","LU1974910355.USD","IE00BKPKM429.USD","LU1035775433.USD","LU1983299246.USD","SG9999015978.USD","ELIL","LU0689472784.USD","LU1145028129.USD","LU2237443465.HKD","SG9999001176.USD","LU0058720904.USD","IE00B1XK9C88.USD","LU0096364046.USD","IE00BJLML261.HKD","LU2456880835.USD","LU2468319806.SGD","SG9999018857.SGD","LU0823434740.USD","LU2417539215.USD","LU2023250504.SGD","SG9999014880.SGD","SG9999015952.SGD","IE00BJJMRZ35.SGD","LU0456855351.SGD","LU1093756168.USD","BK4588","LU2896262040.SGD","IE0004445015.USD","PJP","LU1291159041.SGD","LU1366192091.USD","LU2168563687.JPY","ILDR","LU0289739699.SGD","SG9999014914.USD","LU0323591593.USD","LU0234572021.USD","LLII","HRTS","LU2746668974.SGD","SGXZ51526630.SGD","SGXZ31699556.SGD","IE00BFSS7M15.SGD","LU0353189763.USD","SG9999014906.USD","LU0353189680.USD","LU1023059063.AUD","LU2552382132.HKD","IE00B1BXHZ80.USD","LU0417517546.SGD","LU2028103732.USD","IE00BJJMRY28.SGD","LU0345770993.USD","LU0889565916.HKD","LU2237443382.USD","LU0471298777.SGD","LU1712237335.SGD","BK4533","LU2756315664.SGD","LU2236285917.USD","AGNG","LU2265009873.SGD","LU2462157665.USD","PPH","JDOC","IE00B775H168.HKD","SG9999015945.SGD","IE00BJJMRX11.SGD","LU1069344957.HKD","IE00BN29S564.USD","LLYX","LU2237443549.SGD","LU2168564149.EUR","LU1868837136.USD","LU2089284900.SGD","LU2491050071.SGD","LU0158827948.USD","LU0256863811.USD","LU2089984988.USD","LU2237443895.HKD","LU0158827781.USD","LU2023250330.USD","LU0466842654.USD","LU0471298694.HKD","LU0354030511.USD","ELIS","LU2168564222.USD","RXL","LU0133085943.USD","MEDI","LU0820562030.AUD","LU0320765059.SGD","LU0203201768.USD","LU1989771016.USD","IE00BFTCPJ56.SGD","MHIP","LU1548497426.USD","LU2361044949.HKD","LU0964807845.USD","TMED","LU0122379950.USD","LU0203202063.USD","LU1061106388.HKD","LU1917777945.USD","LU2471134952.CNY","SGXZ57979304.SGD","LU2471134523.USD","IE0009355771.USD","LU0094547139.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671240410","title":"Eli Lilly - to Submit Biologics License Application for Retatrutide in Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2671240410","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671240410?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:00","pubTimestamp":1790719224,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1YN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0943347566.SGD","LU1057294990.SGD","LU2089284900.SGD","SG9999018865.SGD","LU1988902786.USD","LU2168564065.EUR","LU0320765992.SGD","LU1064131342.USD","IE00BN29S564.USD","LU0210536198.USD","LU2111349929.HKD","LU2211815571.USD","LU2324357040.USD","LU1868836591.USD","HRTS","MEDI","IE00BK4W5M84.HKD","LU2456880835.USD","BK4599","LU0106261372.USD","LU1551013342.USD","IE00BJJMRX11.SGD","LU0889565916.HKD","LU0689472784.USD","CANC","LU1989771016.USD","GB00BDT5M118.USD","TMED","IE00BFSS7M15.SGD","LU2237443382.USD","LU2264538146.SGD","IE0004445239.USD","LLYZ","MEDX","IE0002141913.USD","LU0345770308.USD","LU0820562030.AUD","LU0238689110.USD","IE00B2B36J28.USD","LU2112291526.USD","WDNA","LU0354030438.USD","LU2746668974.SGD","LU1023059063.AUD","LU2471134879.HKD","LU0354030511.USD","LU1720051017.SGD","SG9999018857.SGD","LU0109391861.USD","LU2552382215.SGD","LU0203201768.USD","LU2750360641.GBP","FTXH","LU0708995401.HKD","BK4533","LU2360106947.USD","MHIP","LU0323591593.USD","LU0266013472.USD","SGXZ31699556.SGD","LU2213496289.HKD","IE00BJLML261.HKD","LU0198837287.USD","LU0353189763.USD","LU0456855351.SGD","IE00BJJMRZ35.SGD","SG9999015945.SGD","SG9999015986.USD","LU2237443549.SGD","LU1814569148.SGD","LU2106854487.HKD","LU1232071149.USD","LU2237443465.HKD","SGXZ51526630.SGD","LU2063271972.USD","LU2361044865.SGD","ELIS","BK4007","IE0001KFT4U8.USD","LU1280957306.USD","SG9999001176.USD","IE00B775H168.HKD","LU2471134523.USD","SG9999013999.USD","BK4585","SGXZ99366536.SGD","VHT","LU0820561909.HKD","LU1551013425.SGD","LU2602419157.SGD","LU1983299246.USD","LU0320765059.SGD","LU0820561818.USD","LU2023250330.USD","JDOC","LU1127390331.HKD","LU2168564222.USD","IE0009355771.USD","LU0203202063.USD","LU0234572021.USD","LU0640476718.USD","LU1366192091.USD","LU1868837300.USD","LU1868836757.USD","LU0353189680.USD","THNR","SG9999001176.SGD","XLV","IE00BWXC8680.SGD","LU1323610961.USD","LU1623119135.USD","LU1979441026.SGD","SG9999014880.SGD","IE00B4JS1V06.HKD","IE00B7KXQ091.USD","IE00BJJMRY28.SGD","IE00B4R5TH58.HKD","BK4588","IE00BFTCPJ56.SGD","LU0289739699.SGD","PPH","LU0225283273.USD","LU1093756325.SGD","FHLC","LU2087625088.SGD","LU2237443895.HKD","LU2462591350.SGD","LU2468319806.SGD","SG9999014914.USD","LU0174119429.USD","LU2417539215.USD","ILDR","LU1917777945.USD","LU2552382132.HKD","LU0385154629.USD","BK4534","LLYX","LU0079474960.USD","LU2357305700.SGD","LU1629891620.HKD","LU1691799644.USD","LU2265009873.SGD","LU2552382058.USD","LU2168564495.EUR","LU1035775433.USD","LU2756315318.SGD","LU0417517546.SGD","LLY","LU1712237335.SGD","BK4516","IE0005OL40V9.USD","LU0096364046.USD","LU0471298777.SGD","OZEM","LU0114720955.EUR","LU0006306889.USD","LU0256863811.USD","LU0094547139.USD","LU1720051108.HKD","LU0683600562.USD","LU2471134796.USD","LU0058720904.USD","LU0823416689.USD","LU0345770993.USD","LU2471134952.CNY","IE00BFSS8Q28.SGD","LU0133085943.USD","AGNG","IE0004445015.USD","LU1267930730.SGD","IE00BK4W5L77.USD","LU0882574055.USD","LU2168564149.EUR","LU0256863902.USD","LU1061106388.HKD","GDOC","LU0316494557.USD","LU0823434583.USD","LU2089984988.USD","LU2361044949.HKD","LU2750360997.AUD","SG9999014898.SGD","IE00B1XK9C88.USD","LU1868837136.USD","LU0823434740.USD","LU0158827781.USD","LU2237438978.USD","LU2271345857.HKD","LU1093756168.USD","SG9999015952.SGD","LU2023251221.USD","LU2089283258.USD","LU1145028129.USD","LU2491050154.USD","LU2236285917.USD","ELIL","LU0432979614.USD","IE00B1BXHZ80.USD","SG9999017495.SGD","LU0787776722.HKD","SGXZ81514606.USD","LU2461242641.AUD","LU2756315664.SGD","LU1548497426.USD","LU0122379950.USD","SG9999015978.USD","LU0466842654.USD","LU1804176565.USD","LU0882574139.USD","LU2491050071.SGD","LU0786609619.USD","LU1974910355.USD","LU2896262040.SGD","SGXZ57979304.SGD","SG9999014906.USD","BK4581","IYH","CURE","LU2108987350.USD","LU1291159041.SGD","LU2168563687.JPY","RXL","LU2237443622.USD","TRUH","LU0672654240.SGD","LU2023250504.SGD","LU0158827948.USD","LU2028103732.USD","LU2237443978.SGD","LU0097036916.USD","LU2361045086.USD","LU2491049909.HKD","IE00BKPKM429.USD","LU2462157665.USD","LU1868836914.USD","IHE","LLII","IE00BJT1NW94.SGD","PJP","IXJ","LU0061475181.USD","LU1069344957.HKD","IE00BKDWB100.SGD","LU2746668461.USD","LU0109394709.USD","LU0471298694.HKD","LU0964807845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671240400","title":"Eli Lilly - 59.5% of Retatrutide 12 Mg Participants no Longer Meet Bmi Criteria for Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671240400","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671240400?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:00","pubTimestamp":1790719224,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1YN:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WDNA","LU0708995401.HKD","LU2087625088.SGD","GB00BDT5M118.USD","LU1712237335.SGD","LU0964807845.USD","LU1629891620.HKD","SGXZ57979304.SGD","LU1868837136.USD","SGXZ81514606.USD","LU0345770308.USD","SG9999001176.SGD","LU1291159041.SGD","LU2746668461.USD","LU0385154629.USD","MHIP","SG9999014906.USD","LU1804176565.USD","LU2471134879.HKD","LU2168563687.JPY","RXL","SGXZ31699556.SGD","IE00B775H168.HKD","LU0114720955.EUR","LU0471298694.HKD","LU2237443978.SGD","LU2324357040.USD","LU1093756325.SGD","LU2265009873.SGD","LU2417539215.USD","LU1548497426.USD","LU1064131342.USD","LU2361044865.SGD","BK4588","XLV","LU2108987350.USD","BK4516","LU0466842654.USD","LU2360106947.USD","LU0882574055.USD","PPH","PJP","LU1145028129.USD","IE0002141913.USD","LU2237443549.SGD","FTXH","LU0210536198.USD","LU2491049909.HKD","LU2756315664.SGD","IE00BKDWB100.SGD","LU2089284900.SGD","VHT","IE0009355771.USD","IE00BJJMRX11.SGD","IE00BK4W5M84.HKD","LU2023250504.SGD","LU0943347566.SGD","LU2213496289.HKD","LU2602419157.SGD","SG9999015945.SGD","BK4585","BK4581","LLY","SG9999014880.SGD","ELIS","LU0823416689.USD","LU1551013342.USD","SG9999013999.USD","GDOC","LLYX","LU0058720904.USD","IE00BJLML261.HKD","LU0471298777.SGD","LU2023251221.USD","BK4534","LU0109391861.USD","LU0456855351.SGD","LU1057294990.SGD","LU0109394709.USD","LU1061106388.HKD","LU2896262040.SGD","LU1868836591.USD","LU2491050154.USD","LU2361045086.USD","LU0417517546.SGD","LU0234572021.USD","LU0203202063.USD","LU0133085943.USD","LU0323591593.USD","LU2236285917.USD","LU1323610961.USD","MEDX","LU2168564222.USD","LU0106261372.USD","ILDR","IE0001KFT4U8.USD","LU1280957306.USD","LU2111349929.HKD","LU0097036916.USD","LU1979441026.SGD","LU1069344957.HKD","LU2237443382.USD","LU0096364046.USD","LU2750360997.AUD","LU1267930730.SGD","LU2089283258.USD","THNR","IE00BFTCPJ56.SGD","LU0266013472.USD","CURE","BK4533","IE00BFSS7M15.SGD","LU0320765059.SGD","LU0158827948.USD","LU0320765992.SGD","HRTS","LU1093756168.USD","TMED","LU2028103732.USD","LU2750360641.GBP","LU1127390331.HKD","LU0238689110.USD","LU2237443465.HKD","LU0354030438.USD","LU1720051017.SGD","LU0345770993.USD","IE0005OL40V9.USD","SG9999015952.SGD","LU1623119135.USD","LLII","LU2468319806.SGD","LU2471134523.USD","SGXZ99366536.SGD","LU1868837300.USD","LU1868836757.USD","LU2237438978.USD","LU2471134952.CNY","LU0289739699.SGD","LU0316494557.USD","MEDI","CANC","LU0158827781.USD","LU1974910355.USD","LU1988902786.USD","LU2756315318.SGD","IE00BWXC8680.SGD","LU0079474960.USD","LU2211815571.USD","LU0174119429.USD","LU1917777945.USD","SG9999015978.USD","SGXZ51526630.SGD","IE00B4JS1V06.HKD","IXJ","SG9999001176.USD","SG9999014914.USD","LU0823434583.USD","LU0889565916.HKD","LU2023250330.USD","LU0354030511.USD","LU0820562030.AUD","LU1814569148.SGD","LLYZ","IE00BJT1NW94.SGD","TRUH","LU2456880835.USD","AGNG","LU0689472784.USD","LU2746668974.SGD","LU1035775433.USD","LU0432979614.USD","SG9999014898.SGD","ELIL","IE00B2B36J28.USD","IE00BJJMRY28.SGD","LU0256863902.USD","LU1720051108.HKD","IE00BKPKM429.USD","IE00B1XK9C88.USD","IE00B1BXHZ80.USD","LU0672654240.SGD","SG9999015986.USD","LU2112291526.USD","LU2063271972.USD","LU2471134796.USD","IE00BK4W5L77.USD","IE00BJJMRZ35.SGD","LU0820561818.USD","IE00B4R5TH58.HKD","LU2271345857.HKD","LU2552382058.USD","LU0353189680.USD","LU0122379950.USD","LU0786609619.USD","LU1691799644.USD","IE0004445015.USD","BK4599","SG9999018865.SGD","LU0256863811.USD","LU2462591350.SGD","JDOC","LU0823434740.USD","SG9999017495.SGD","LU2106854487.HKD","LU0820561909.HKD","LU2089984988.USD","IE00B7KXQ091.USD","LU0225283273.USD","IE00BFSS8Q28.SGD","LU0353189763.USD","LU0882574139.USD","LU1366192091.USD","LU1989771016.USD","LU2168564065.EUR","LU2168564495.EUR","LU0006306889.USD","LU2357305700.SGD","LU2461242641.AUD","IYH","LU2237443895.HKD","LU0787776722.HKD","LU2237443622.USD","IE0004445239.USD","LU1551013425.SGD","LU1868836914.USD","LU1232071149.USD","LU0640476718.USD","IHE","LU0203201768.USD","BK4007","LU0683600562.USD","LU2491050071.SGD","LU2552382215.SGD","OZEM","FHLC","LU0094547139.USD","LU1023059063.AUD","LU2552382132.HKD","LU0061475181.USD","LU1983299246.USD","LU2168564149.EUR","LU2264538146.SGD","LU2361044949.HKD","LU2462157665.USD","LU0198837287.USD","IE00BN29S564.USD","SG9999018857.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671247344","title":"AbbVie Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2671247344","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671247344?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:31","pubTimestamp":1790713860,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  slipped 1.12% to $263.29 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.17% to 7,670.84 and Dow Jones Industrial Average  falling 0.26% to 51,349.92.AbbVie Inc. closed 2.26% short of its 52-week high of $269.39, which the company reached on September 23rd.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 1.61% to $267.57, Pfizer Inc.  remained unchanged, and Amgen Inc.  rose 1.32% to $423.64.Trading volume  remained 775,865 below its 50-day average volume of 4.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 29, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2433249047.HKD","LU2129689431.USD","LU1989772840.SGD","LU2357305700.SGD","IE0002141913.USD","LU0098860793.USD","IE00B19Z3B42.SGD","LU1670628061.USD","RXL","IE0000B7K699.USD","LU0289739699.SGD","LU0868494708.USD","LU0289739343.SGD","BK4581","LU0203345920.USD","LU0029864427.USD","IE00BN8TJ469.HKD","LU1720051017.SGD","IE000F7OJYX1.SGD","LU1037948541.HKD","LU0868494617.USD","IE00BJJMRZ35.SGD","SG9999003800.SGD","LU0511384066.AUD","BK4534","IE00BBT3K403.USD","LU1585245621.USD","LU1291159041.SGD","MEDX","IE00BLSP4452.SGD","IE00BFTCPJ56.SGD","IXJ","LU1989771016.USD","IE0002270589.USD","LU0057025933.USD","LU1983299246.USD","LU0170899867.USD","LU0795875086.SGD","LU0965509283.SGD","LU2347655073.USD","LU0124676726.USD","LU0234572021.USD","LU1720051108.HKD","IE00BJT1NW94.SGD","SG9999015945.SGD","BK4533","AGNG","LU1839511570.USD","LU0472753341.HKD","LU0726765562.USD","LU2347655156.SGD","LU1267930573.SGD","SG9999015986.USD","LU0985320562.USD","LU2468319806.SGD","LU0203347892.USD","IE00BSNM7G36.USD","IE00BDGV0183.EUR","LU0256863902.USD","XLV","LU0158827948.USD","LU1267930490.SGD","LU0882574055.USD","SG9999015952.SGD","LU1718418525.SGD","LU0965509010.AUD","LU1037948897.HKD","LU1093756168.USD","BK4139","LU1670627923.USD","LU0795875169.SGD","LU2089284900.SGD","LU1934455277.USD","LU1244550494.USD","IE000SO60NU8.SGD","LU2237443622.USD","LU1551013425.SGD","LU0861579265.USD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU1923622614.USD","LU2357627491.SGD","LU0943347566.SGD","LU0859254822.USD","FTXH","LU0310799852.SGD","LU1732799900.SGD","LU0114720955.EUR","LU0823416689.USD","LU1093756325.SGD","LU0310800379.SGD","LU0417517546.SGD","LU0198837287.USD","LU0965509101.SGD","IE00BLSP4239.USD","IYH","LU1074936037.SGD","LU1496350171.SGD","LU0820561909.HKD","LU0689626769.HKD","IE00BGHQF631.EUR","FHLC","LU2129689514.USD","LU2129689605.HKD","LU0234570918.USD","PPH","LU0738911758.USD","BK4585","LU2133065610.SGD","IE00BVYPNW00.USD","LU2112291526.USD","SG9999011175.SGD","LU2237443978.SGD","IE00B2B36J28.USD","LU0069063385.USD","LU0965508806.USD","LU0211327993.USD","BK4550","LU1244550577.SGD","IE00BVYPNV92.GBP","GLAM","IE000BZT7R73.USD","IE00B19Z3581.USD","LU1430594728.SGD","LU0708994859.HKD","LU0256863811.USD","LU2087621335.USD","LU1551013342.USD","LU1496350502.SGD","VHT","SG9999001440.SGD","LU1061106388.HKD","LU0661504455.SGD","LU1236620834.HKD","LU2125909247.SGD","LU0912757837.SGD","LU0128525929.USD","LU0942090050.USD","LU1244550221.USD","LU0545039389.USD","LU2125909593.SGD","JDOC","BK4559","ABBV","TRUH","LU0058720904.USD","IE000MB6IJN5.SGD","LU1934455194.USD","LU1989772923.USD","LU0289961442.SGD","LU1162221912.USD","BK4588","LU2237443895.HKD","LU1003077747.HKD","BK4566","LU0320765646.SGD","IE00B42XCP33.USD","LU0456855351.SGD","LU1732800096.USD","IE0009355771.USD","LU0211328371.USD","SG9999015978.USD","LU0553294199.USD","LU2237443549.SGD","LU1023059063.AUD","LU2089984988.USD","LU0689472784.USD","LU0432979614.USD","PJP","LU0122379950.USD","LU0949170772.SGD","IE0004445239.USD","LU0395794307.EUR","LU1236620750.USD","LU2089283258.USD","LU2237443382.USD","LU2237443465.HKD","IE00B3PB1722.GBP","LU1929549753.HKD","LU1934455863.HKD","LU2023251221.USD","IE000WAW04H5.SGD","LU0820561818.USD","LU1548497426.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":13,"totalSize":334,"code":"91000000","status":"200"}]}}